Abolis Biotechnologies Brings French Industrial Biotech Excellence To Saudi Arabia, Driving The Kingdom's Shift Toward A Sustainable And Sovereign Bioeconomy A Momentum Reinforced By Its Participation In The Booster Grow Global KSA Program

(MENAFN- Mid-East Info) Riyadh, Saudi Arabia – December 2025 – Abolis Biotechnologies, a pioneering actor in industrial biotechnology, is proud to have participated in the fourth edition of the Booster Grow Global KSA program, a strategic initiative aimed at strengthening technological collaborations between France and Saudi Arabia. This recognition confirms the relevance of our innovative and sustainable offering, which directly addresses the economic diversification and ecological transition ambitions promoted by the Kingdom's Vision 2030.

An innovative technology tailored to the Saudi market
At Abolis, we develop customized microorganisms capable of producing bio-sourced, high-value ingredients through fermentation processes, in place of traditional methods. Our solutions address growing needs in the health, cosmetics, nutrition, and chemical sectors, ensuring a stable, secure, and more environmentally friendly supply perfectly aligned with Saudi Arabia's sustainable growth priorities.

Since its creation in 2014, Abolis has built numerous partnerships with players of all sizes, ranging from start-ups to large industrial groups, in Europe and the United States.
More recently, in 2024, Abolis's journey was marked by a €35 million fundraising round supported by prestigious international partners such as L'Oréal and Evonik. These partnerships enable us to accelerate industrial development and bring our innovative products to market, ensuring quality and reliability for our clients and investors.

Development in Saudi Arabia
Abolis is currently engaging with regional companies and institutions to tailor its technologies to local needs, paving the way for future joint projects in the Kingdom. We are establishing strong collaborations with regional companies and institutions to adapt our technologies to local requirements and contribute to developing a competitive and sovereign biotech ecosystem.

Our mission is fully aligned with the objectives of Vision 2030, which aims to strengthen bioeconomy and
sustainability. We bring the Kingdom cutting-edge expertise in biosynthesis to secure and locally produce
essential ingredients, thus supporting the country's industrial transformation and economic development.

The rapidly expanding Saudi biotechnology market offers significant potential, which we intend to harness
through the development of strategic partnerships and the operational adaptation of our innovative solutions. Our ambition is to become a partner of choice, offering sustainable technologies to meet the Kingdom's industrial needs in the short, medium, and long term.

We are actively working to create alliances with key regional players to maximize technological and commercial impact, accelerate knowledge transfer, and strengthen a local, competitive biotechnology sector fully in synergy with government ambitions.

“We believe that true innovation happens through collaboration. By engaging with Saudi institutions and companies, we want to co-develop bio-based technologies that contribute to the Kingdom's long-term goals in sustainability and industrial sovereignty.” – Gwenaël Servant, VP Business & Strategy

MENAFN09122025005446012082ID1110459119